• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

G蛋白偶联受体依赖受体活性修饰蛋白的选择性肽识别的结构基础

Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor.

作者信息

Booe Jason M, Walker Christopher S, Barwell James, Kuteyi Gabriel, Simms John, Jamaluddin Muhammad A, Warner Margaret L, Bill Roslyn M, Harris Paul W, Brimble Margaret A, Poyner David R, Hay Debbie L, Pioszak Augen A

机构信息

Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.

School of Biological Sciences and Maurice Wilkins Centre, University of Auckland, Auckland 1142, New Zealand.

出版信息

Mol Cell. 2015 Jun 18;58(6):1040-52. doi: 10.1016/j.molcel.2015.04.018. Epub 2015 May 14.

DOI:10.1016/j.molcel.2015.04.018
PMID:25982113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4504005/
Abstract

Association of receptor activity-modifying proteins (RAMP1-3) with the G protein-coupled receptor (GPCR) calcitonin receptor-like receptor (CLR) enables selective recognition of the peptides calcitonin gene-related peptide (CGRP) and adrenomedullin (AM) that have diverse functions in the cardiovascular and lymphatic systems. How peptides selectively bind GPCR:RAMP complexes is unknown. We report crystal structures of CGRP analog-bound CLR:RAMP1 and AM-bound CLR:RAMP2 extracellular domain heterodimers at 2.5 and 1.8 Å resolutions, respectively. The peptides similarly occupy a shared binding site on CLR with conformations characterized by a β-turn structure near their C termini rather than the α-helical structure common to peptides that bind related GPCRs. The RAMPs augment the binding site with distinct contacts to the variable C-terminal peptide residues and elicit subtly different CLR conformations. The structures and accompanying pharmacology data reveal how a class of accessory membrane proteins modulate ligand binding of a GPCR and may inform drug development targeting CLR:RAMP complexes.

摘要

受体活性修饰蛋白(RAMP1 - 3)与G蛋白偶联受体(GPCR)降钙素受体样受体(CLR)相结合,能够选择性识别在心血管和淋巴系统中具有多种功能的肽类——降钙素基因相关肽(CGRP)和肾上腺髓质素(AM)。肽类如何选择性地结合GPCR:RAMP复合物尚不清楚。我们分别报告了分辨率为2.5 Å和1.8 Å的CGRP类似物结合的CLR:RAMP1细胞外结构域异二聚体以及AM结合的CLR:RAMP2细胞外结构域异二聚体的晶体结构。这些肽类类似地占据CLR上的一个共享结合位点,其构象的特征是在其C末端附近有一个β-转角结构,而不是与结合相关GPCR的肽类常见的α-螺旋结构。RAMP通过与可变的C末端肽残基形成不同的接触来扩大结合位点,并引发略有不同的CLR构象。这些结构和相关的药理学数据揭示了一类辅助膜蛋白如何调节GPCR的配体结合,并可能为靶向CLR:RAMP复合物的药物开发提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/864e/4504005/bf768ee19fbf/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/864e/4504005/277bc671b74f/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/864e/4504005/81f90ed94361/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/864e/4504005/cac497c58415/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/864e/4504005/bdc16dc199f0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/864e/4504005/e7e30e3b94a4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/864e/4504005/050bb1619187/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/864e/4504005/8e8fe36aebe5/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/864e/4504005/bf768ee19fbf/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/864e/4504005/277bc671b74f/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/864e/4504005/81f90ed94361/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/864e/4504005/cac497c58415/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/864e/4504005/bdc16dc199f0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/864e/4504005/e7e30e3b94a4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/864e/4504005/050bb1619187/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/864e/4504005/8e8fe36aebe5/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/864e/4504005/bf768ee19fbf/gr7.jpg

相似文献

1
Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor.G蛋白偶联受体依赖受体活性修饰蛋白的选择性肽识别的结构基础
Mol Cell. 2015 Jun 18;58(6):1040-52. doi: 10.1016/j.molcel.2015.04.018. Epub 2015 May 14.
2
Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.受体活性修饰蛋白依赖性突变对降钙素受体样受体的影响:对肾上腺髓质素和降钙素基因相关肽药理学的影响。
Br J Pharmacol. 2014 Feb;171(3):772-88. doi: 10.1111/bph.12508.
3
Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists.通过合理设计强效肾上腺髓质素和降钙素基因相关肽拮抗剂探究受体活性修饰蛋白对 G 蛋白偶联受体配体选择性的调控机制。
Mol Pharmacol. 2018 Apr;93(4):355-367. doi: 10.1124/mol.117.110916. Epub 2018 Jan 23.
4
Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.结构-功能分析揭示了肾上腺髓质素 2/中介素的三 β-转角受体结合构象,并能够设计肽类拮抗剂。
J Biol Chem. 2018 Oct 12;293(41):15840-15854. doi: 10.1074/jbc.RA118.005062. Epub 2018 Aug 23.
5
Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.通过连接的 RAMP-降钙素受体样受体细胞外域融合蛋白对 CGRP 和肾上腺髓质素肽的选择性结合。
Protein Sci. 2013 Dec;22(12):1775-85. doi: 10.1002/pro.2377. Epub 2013 Oct 19.
6
Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.降钙素与胰淀素受体肽相互作用机制:深入了解受体活性修饰蛋白对降钙素受体的肽结合模式及变构调节
J Biol Chem. 2016 Apr 15;291(16):8686-700. doi: 10.1074/jbc.M115.713628. Epub 2016 Feb 19.
7
Receptor Activity-modifying Proteins 2 and 3 Generate Adrenomedullin Receptor Subtypes with Distinct Molecular Properties.受体活性修饰蛋白2和3产生具有不同分子特性的肾上腺髓质素受体亚型。
J Biol Chem. 2016 May 27;291(22):11657-75. doi: 10.1074/jbc.M115.688218. Epub 2016 Mar 24.
8
Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.外源性肾上腺髓质素和降钙素基因相关肽对Ramp和Calcrl基因缺陷小鼠的心血管作用。
Peptides. 2017 Feb;88:1-7. doi: 10.1016/j.peptides.2016.12.002. Epub 2016 Dec 8.
9
Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs.降钙素基因相关肽和肾上腺髓质素受体与Gs偶联中依赖和不依赖受体活性修饰蛋白的激活机制
Biochem Pharmacol. 2017 Oct 15;142:96-110. doi: 10.1016/j.bcp.2017.07.005. Epub 2017 Jul 11.
10
Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.鉴定对降钙素基因相关肽、肾上腺髓质素和胰淀素受体功能重要的N端受体活性修饰蛋白残基。
Mol Pharmacol. 2008 Oct;74(4):1059-71. doi: 10.1124/mol.108.047142. Epub 2008 Jul 1.

引用本文的文献

1
Amylin receptor subunit interactions are modulated by agonists and determine signaling.胰淀素受体亚基相互作用受激动剂调节并决定信号传导。
Sci Signal. 2025 Aug 19;18(900):eadt8127. doi: 10.1126/scisignal.adt8127.
2
Amylin Receptor 1 Mutagenesis Revealed a Potential Role of Calcitonin Serine 29 in Receptor Interaction.胰淀素受体1诱变揭示了降钙素丝氨酸29在受体相互作用中的潜在作用。
Biomedicines. 2025 Jul 21;13(7):1787. doi: 10.3390/biomedicines13071787.
3
Determinants of Improved CGRP Peptide Binding Kinetics Revealed by Enhanced Molecular Simulations.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.受体活性修饰蛋白依赖性突变对降钙素受体样受体的影响:对肾上腺髓质素和降钙素基因相关肽药理学的影响。
Br J Pharmacol. 2014 Feb;171(3):772-88. doi: 10.1111/bph.12508.
3
Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.
增强分子模拟揭示CGRP肽结合动力学改善的决定因素
bioRxiv. 2025 Jun 17:2025.06.13.659569. doi: 10.1101/2025.06.13.659569.
4
design of miniprotein agonists and antagonists targeting G protein-coupled receptors.靶向G蛋白偶联受体的微型蛋白质激动剂和拮抗剂的设计
bioRxiv. 2025 Jun 5:2025.03.23.644666. doi: 10.1101/2025.03.23.644666.
5
Characterization of the Two-Domain Peptide Binding Mechanism of the Human CGRP Receptor for CGRP and the Ultrahigh Affinity ssCGRP Variant.人降钙素基因相关肽(CGRP)受体对CGRP及超高亲和力单链CGRP变体的双结构域肽结合机制的表征
Biochemistry. 2025 Apr 15;64(8):1770-1787. doi: 10.1021/acs.biochem.4c00812. Epub 2025 Apr 2.
6
Amylin receptor subunit interactions are modulated by agonists and determine signaling.胰淀素受体亚基相互作用受激动剂调节并决定信号传导。
bioRxiv. 2024 Oct 9:2024.10.09.617487. doi: 10.1101/2024.10.09.617487.
7
Extracellular bimolecular fluorescence complementation for investigating membrane protein dimerization: a proof of concept using class B GPCRs.用于研究膜蛋白二聚化的细胞外双分子荧光互补:使用 B 类 GPCR 的概念验证。
Biosci Rep. 2024 Oct 30;44(10). doi: 10.1042/BSR20240449.
8
Functional Analysis and Tissue-Specific Expression of Calcitonin and CGRP with RAMP-Modulated Receptors CTR and CLR in Chickens.鸡中降钙素和降钙素基因相关肽与RAMP调节受体CTR和CLR的功能分析及组织特异性表达
Animals (Basel). 2024 Mar 30;14(7):1058. doi: 10.3390/ani14071058.
9
Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins.阐明 G 蛋白偶联受体和受体活性修饰蛋白的相互作用组。
Pharmacol Rev. 2023 Jan;75(1):1-34. doi: 10.1124/pharmrev.120.000180. Epub 2022 Dec 8.
10
Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin G protein-coupled receptor.肾上腺髓质素2/中间介质是一种解离速率慢、作用时间长的肾上腺髓质素G蛋白偶联受体内源性激动剂。
bioRxiv. 2023 Jan 13:2023.01.13.523955. doi: 10.1101/2023.01.13.523955.
通过连接的 RAMP-降钙素受体样受体细胞外域融合蛋白对 CGRP 和肾上腺髓质素肽的选择性结合。
Protein Sci. 2013 Dec;22(12):1775-85. doi: 10.1002/pro.2377. Epub 2013 Oct 19.
4
G-protein-coupled receptor 30 interacts with receptor activity-modifying protein 3 and confers sex-dependent cardioprotection.G 蛋白偶联受体 30 与受体活性修饰蛋白 3 相互作用,赋予性别依赖性心脏保护作用。
J Mol Endocrinol. 2013 Jul 3;51(1):191-202. doi: 10.1530/JME-13-0021. Print 2013.
5
Identification of key residues involved in adrenomedullin binding to the AM1 receptor.鉴定与 AM1 受体结合的肾上腺髓质素的关键残基。
Br J Pharmacol. 2013 May;169(1):143-55. doi: 10.1111/bph.12118.
6
Bacterial expression and purification of a heterodimeric adrenomedullin receptor extracellular domain complex using DsbC-assisted disulfide shuffling.利用DsbC辅助的二硫键重排进行异源二聚体肾上腺髓质素受体胞外域复合物的细菌表达与纯化。
Protein Expr Purif. 2013 Mar;88(1):107-13. doi: 10.1016/j.pep.2012.11.019. Epub 2012 Dec 13.
7
Structure-activity relationships for α-calcitonin gene-related peptide.α-降钙素基因相关肽的构效关系。
Br J Pharmacol. 2013 Dec;170(7):1308-22. doi: 10.1111/bph.12072.
8
Adrenomedullin Function in Vascular Endothelial Cells: Insights from Genetic Mouse Models.血管内皮细胞中的肾上腺髓质素功能:来自基因小鼠模型的见解
Curr Hypertens Rev. 2011 Dec;7(4):228-239. doi: 10.2174/157340211799304761.
9
Structural basis for extracellular interactions between calcitonin receptor-like receptor and receptor activity-modifying protein 2 for adrenomedullin-specific binding.降钙素受体样受体与受体活性修饰蛋白 2 之间用于肾上腺髓质素特异性结合的细胞外相互作用的结构基础。
Protein Sci. 2012 Feb;21(2):199-210. doi: 10.1002/pro.2003. Epub 2011 Dec 28.
10
Structure of micelle-bound adrenomedullin: a first step toward the analysis of its interactions with receptors and small molecules.胶束结合肾上腺髓质素的结构:分析其与受体和小分子相互作用的第一步。
Biopolymers. 2012 Jan;97(1):45-53. doi: 10.1002/bip.21700. Epub 2011 Aug 9.